{"database": "lobbying", "table": "lobbying_activities", "rows": [[2824163, "1979df22-1a58-42c4-9f86-5a424bfb1565", "Q2", "STRATEGIES 360", 79175, "INNOVA MEDICAL GROUP, INC.", 2022, "second_quarter", "MED", "Issues relating to the FDA approval process for medical testing", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2022-07-18T13:10:02-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2824163"], "units": {}, "query_ms": 0.3728319425135851, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}